Poland· PL-100013962
Chlorocyclinum 3%
A chlortetracycline product containing chlortetracyclini hydrochloridum, registered in Poland by Chema-Elektromet Spółdzielnia Pracy. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Chlortetracycline is registered in 3 of 19 countries.
Countries holding a registration under ATC D06AA02 (chlortetracycline), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Chlortetracycline · ATC D06AA02
3 / 19 countries
- Finlandprice
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Chlortetracyclini hydrochloridum
- Manufacturer
- Chema-Elektromet Spółdzielnia Pracy
- Country
- Poland (PL)
- ATC code
- D06AA02
- ATC class
- Chlortetracycline
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990267613
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlortetracycline in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainDERMOSA AUREOMICINA 30 MG/G POMADATeofarma S.R.L.
- FinlandAureomycinWyeth Lederle Nordiska Ab
- CanadaAUREOMYCIN 220 GZOETIS CANADA INC
- FranceAUREOMYCINE EVANS 1 POUR CENT, pommade ophtalmiqueSCA PHARMA
- NorwayAureomycin
- GermanyAureomycinAbanta Pharma Gmbh
- United KingdomAureomycine Evans 1% eye ointmentImported (France)
- BelgiumAureomycin 1 %BePharBel Manufacturing
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Aureomycin
- Germany · Aureomycin
- Spain · Dermosa Aureomicina, Oftalmolosa Cusí Aureomicina
- France · Aureomycine Evans
- Italy · Aureomicina
- Luxembourg · Aureomycin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42886dc4-0b08-4f22-9b01-0344744ec478 GET /v1/drugs/42886dc4-0b08-4f22-9b01-0344744ec478?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "30 mg/g",
"packaging": "05909990267613 ¦ Rp ¦ 2441\n1 tuba 10 g",
"substance": "Chlortetracyclini hydrochloridum 30 mg/g",
"common_name": "Chlortetracyclini hydrochloridum",
"pl_product_id": "100013962",
"pozwolenie_nr": "02676",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about chlortetracycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.